Last updated on April 2017

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation
  • Age: Between 21 - 100 Years
  • Gender: Male or Female
  • Other:
    Fibrillation) with electrocardiographic documentation or patients with prevalent (existing
    diagnosis) AF who had initiation or transition to a FXa (Factor Xa) inhibitor or a direct
    thrombin inhibitor within the preceding 3 months - anticipated ability to adhere to local
    regularly scheduled follow-up visits

You may not be eligible for this study if the following are true:

  • Atrial flutter only - Anticipated life expectancy less than 6 months - short lasting
    AF secondary to a reversible condition (e.g. hyperthyroidism, pulmonary embolism,
    post-cardiothoracic surgery) - Participation in a randomized trial of anticoagulation
    for AF at the time of enrollment - Was enrolled in the ORBIT-I Registry

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.